Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00691119 · ClinicalTrials.gov registry record · NA

Relaxation and Visualization Therapy for Breast Cancer Patients

A NA study, sponsored by National University of Natural Medicine.

Terminated
Registry status
NA
Development phase
9
Enrollment target

NCT00691119 is a NA study that was terminated before completion, run by National University of Natural Medicine. The registered enrollment target is 9 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00691119, a NA study, was terminated before completion, sponsored by National University of Natural Medicine.

TERMINATED
Registry status
NA
Development phase
9 participants
Enrollment target

Study Summary

The purpose of this study is to find out if it is possible to study relaxation and visualization therapy (RVT) with individuals that have breast cancer. We will also look at what effects, the good and bad, RVT has when used with radiation therapy. We are interested in how RVT may relate to energy, quality of life, stress, and the immune system. Relaxation and Visualization therapy will lead participants through a practice of physical relaxation and then a step by step visualization. In this study, participants will be led through an RVT exercise, providing an interactive process. In addition, women will perform solitary RVT exercises at home on weekends. Participants for this study will be drawn from two OHSU physicians' regular patient base. To be sure that we are testing the effects of RVT alone, we will use three groups. The three groups will be RVT, education, and a control. The RVT group will receive RVT with radiation, and the education group will receive breast cancer related health education with radiation. The third group will receive no treatment beyond radiation. This third group is called the control. The entire study will last for approximately twelve weeks. For the first 6 weeks, each participant will be receiving radiation therapy. We will be particularly interested in the effects that RVT may have on energy, quality of life, stress, and the immune system. No experimental drug or device will be used during the study.

Interventions

  • OTHER Health education
  • BEHAVIORAL Relaxation and Visualization Therapy

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2008-12
Est. Completion 2009-12
Phase NA

What the Registry Record Tells You About NCT00691119

The ClinicalTrials.gov registry entry for NCT00691119 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National University of Natural Medicine, which has 30 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Health education is the first listed.

NCT00691119 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00691119 about?

NCT00691119 is a clinical study titled "Relaxation and Visualization Therapy for Breast Cancer Patients". The purpose of this study is to find out if it is possible to study relaxation and visualization therapy (RVT) with individuals that have breast cancer. We will also look at what effects, the good and bad, RVT has when used with radiation therapy. We are interested in how RVT may relate to energy, q...

What is the current status of trial NCT00691119?

This trial is currently terminated. It is a NA study. The enrollment target is 9 participants. The study started on 2008-12. Estimated completion is 2009-12.

What interventions are being tested in trial NCT00691119?

The interventions under investigation include: Health education (OTHER), Relaxation and Visualization Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT00691119?

This trial is sponsored by National University of Natural Medicine, which has 30 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.